(()=>{"use strict";var e={4899:(e,t,n)=>{n.r(t),n.d(t,{default:()=>ut});var r=n(5861),o=n(885),i=n(2010),l=n(7602),a=n(5004),s=n(4808),d=n(6454),c=n(5705),u=n(4942),f=n(1054),h=n(5326),m=n(4584),y=n(9385),x=(n(9896),n(2955)),p=n(1673),b=n(323),g=n(3838),j=n(884),O=n(3224),v=n(1199),w=n(7955),T=n(3009),L=n(4964),S=m.default.get("window").width,P=m.default.get("window").height;console.log({fullScreenHeight:P}),console.log({fullScreenWidth:S});const N=i.default.create({container:{flex:"1",flexGrow:1,padding:1,justifyContent:"center"},MDLPic:{flex:"1",padding:80,justifyContent:"center"},button:{backgroundColor:"grey",padding:10,margin:.05*S,marginTop:10,marginBottom:10,height:.075*P,width:.9*S,justifyContent:"center",alignItems:"center",borderColor:"black",borderRadius:35,borderWidth:2,fontWeight:"bold",fontStyle:"normal",elevation:3,opacity:.85,shadowColor:"grey",shadowOffset:{width:-10,height:9},shadowOpacity:.5,shadowRadius:2,elevation:5},buttonLandscape:{backgroundColor:"grey",padding:10,margin:.05*S,marginTop:10,marginBottom:10,height:.075*P,width:.9*S,justifyContent:"center",alignItems:"center",borderColor:"black",borderRadius:35,borderWidth:2,fontWeight:"bold",fontStyle:"normal",elevation:3,opacity:.85,shadowColor:"grey",shadowOffset:{width:-10,height:9},shadowOpacity:.5,shadowRadius:2,elevation:5},buttonText:{justifyContent:"center",color:"black",fontWeight:"bold",flexGrow:1,textTransform:"uppercase",alignItems:"center",margin:5,height:.08*P,width:.09*S,fontFamily:"AmericanTypewriter-CondensedBold",textAlign:"center"},buttonTextLandscape:{justifyContent:"contain",color:"black",fontWeight:"bold",flexGrow:1,textTransform:"uppercase",alignItems:"center",margin:5,height:.08*P,width:.09*S,fontFamily:"AmericanTypewriter-CondensedBold",textAlign:"center"},innerTextred:{justifyContent:"space-around",color:"blue",fontWeight:"bold",fontSize:16,textTransform:"uppercase",alignItems:"center",margin:10,fontFamily:"AmericanTypewriter-CondensedBold",textAlign:"center"},innerTextyellow:{justifyContent:"space-around",color:"#EACE09",fontWeight:"bold",fontSize:16,textTransform:"uppercase",alignItems:"center",margin:10,fontFamily:"AmericanTypewriter-CondensedBold",textAlign:"center"},innerTextgreen:{justifyContent:"space-around",color:"green",fontWeight:"bold",fontSize:16,textTransform:"uppercase",alignItems:"center",margin:10,fontFamily:"AmericanTypewriter-CondensedBold",textAlign:"center"},accordionText:{justifyContent:"space-around",alignItems:"center",backgroundColor:"skyblue",color:"black",fontWeight:"bold",fontSize:16,textTransform:"uppercase",fontFamily:"Arial"},baseText:{justifyContent:"center",color:"black",fontWeight:"bold",textTransform:"uppercase",alignItems:"center",margin:10,fontFamily:"Arial",textAlign:"center"},baseText2:{justifyContent:"space-around",color:"black",fontWeight:"bold",textTransform:"uppercase",alignItems:"center",margin:10,fontFamily:"Arial",textAlign:"left"},overlay:{opacity:.5,backgroundColor:"#000000"},superscript:{fontSize:8,lineHeight:8},headerLeft:{marginLeft:20},ContainerPortrait:{flex:1,flexDirection:"column",justifyContent:"center",alignItems:"center"},ContainerLandscape:{flex:1,flexDirection:"column",justifyContent:"center",alignItems:"center"}});var R=n(2629);function C(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function D(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?C(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):C(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const I=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options",children:[(0,R.jsxs)(w.default,{title:"RECOMMENDED REGIMEN",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,D(D({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"metronidazole 500 mg orally 2x/day for 7 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"metronidazole gel 0.75%, one 5 gm applicator intravaginally, 1x/day for 5 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"clindamycin cream 2%, one 5 gm applicator intravaginally, at bedtime for 7 days"})})]}),(0,R.jsxs)(w.default,{title:"ALTERNATIVE REGIMEN",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,D(D({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"clindamycin 300 mg orally 2x/day for 7 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{style:N.accordionText,children:["clindamycin ovules 100 mg intravaginally at bedtime for 3 days",(0,R.jsx)(f.default,{style:{fontSize:8},children:"1"})," OR"]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{style:N.accordionText,children:["secnidazole 2 gm orally in a single dose",(0,R.jsx)(f.default,{style:{fontSize:8,textAlignVertical:"top"},children:"2"})," OR"]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"tinidazole 2 gm orally 1x/day for 2 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"tinidazole 1 gm orally 1x/day for 5 days"})})]})]})})};function A(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function E(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?A(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):A(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const z=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options (see note 3)",titleNumberOfLines:4,children:[(0,R.jsxs)(w.default,{title:"RECOMMENDED REGIMEN",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,E(E({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"doxycycline 100 mg orally 2x/day for 7 days"})})]}),(0,R.jsxs)(w.default,{title:"ALTERNATIVE REGIMEN",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,E(E({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"azithromycin 1 gm orally in a single dose"})})]})]})})};function k(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function M(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?k(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):k(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const V=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1],c=a.useState(!0),u=(0,o.default)(c,2),h=u[0],m=u[1],x=a.useState(!0),p=(0,o.default)(x,2),b=p[0],g=p[1],j=a.useState(!0),S=(0,o.default)(j,2),P=S[0],C=S[1],D=a.useState(!0),I=(0,o.default)(D,2),A=I[0],E=I[1],z=a.useState(!0),k=(0,o.default)(z,2),V=k[0],G=k[1],W=a.useState(!0),B=(0,o.default)(W,2),H=B[0],U=B[1],_=a.useState(!0),F=(0,o.default)(_,2),Y=F[0],q=F[1],J=a.useState(!0),Z=(0,o.default)(J,2),K=Z[0],Q=Z[1],X=a.useState(!0),$=(0,o.default)(X,2),ee=$[0],te=$[1],ne=a.useState(!0),re=(0,o.default)(ne,2),oe=re[0],ie=re[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options",children:[(0,R.jsx)(w.default,{title:"Adults and adolescents",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,M(M({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:(0,R.jsxs)(v.default,{children:[(0,R.jsxs)(w.default,{title:"Recommended Regimens",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,M(M({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"doxycycline 100 mg orally 2x/day for 7 days"})})]}),(0,R.jsxs)(w.default,{title:"Alternate Regimens",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,M(M({},e),{},{icon:h?"folder":"folder-open",color:"blue"}))},onPress:function(){return m(!h)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"azithromycin 1 gm orally in a single dose OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"levofloxacin 500 mg orally 1x/day for 7 days"})})]})]})}),(0,R.jsx)(w.default,{title:"Pregnancy",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,M(M({},e),{},{icon:b?"folder":"folder-open",color:"blue"}))},onPress:function(){return g(!b)},children:(0,R.jsxs)(v.default,{children:[(0,R.jsxs)(w.default,{title:"Recommended Regimens",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,M(M({},e),{},{icon:P?"folder":"folder-open",color:"blue"}))},onPress:function(){return C(!P)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"azithromycin 1 gm orally in a single dose"})})]}),(0,R.jsxs)(w.default,{title:"Alternate Regimens",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,M(M({},e),{},{icon:A?"folder":"folder-open",color:"blue"}))},onPress:function(){return E(!A)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"amoxicillin 500 mg orally 3x/day for 7 days"})})]})]})}),(0,R.jsxs)(w.default,{title:"Infant and children <45 kg (see note 4) (nasopharynx, urogenital, and rectal) ",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,M(M({},e),{},{icon:V?"folder":"folder-open",color:"blue"}))},onPress:function(){return G(!V)},children:[(0,R.jsx)(L.default,{title:"Recommended Regimens",titleNumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"erythromycin base, 50 mg/kg body weight/day orally, divided into 4 doses daily for 14 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"ethylsuccinate, 50 mg/kg body weight/day orally, divided into 4 doses daily for 14 days"})})]}),(0,R.jsxs)(w.default,{title:"Children who weigh \u226545 kg, but who are aged <8 years (nasopharynx, urogenital, and rectal)",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,M(M({},e),{},{icon:H?"folder":"folder-open",color:"blue"}))},onPress:function(){return U(!H)},children:[(0,R.jsx)(L.default,{title:"Recommended Regimens",titleNumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"azithromycin 1 gm orally in a single dose"})})]}),(0,R.jsxs)(w.default,{title:"Children aged \u22658 years (nasopharynx, urogenital, and rectal)",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,M(M({},e),{},{icon:Y?"folder":"folder-open",color:"blue"}))},onPress:function(){return q(!Y)},children:[(0,R.jsx)(L.default,{title:"Recommended Regimens",titleNumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"azithromycin 1 gm orally in a single dose OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"doxycycline 100 mg orally 2x/day for 7 days"})})]}),(0,R.jsx)(w.default,{title:"Neonates:(see note 5) ophthalmia and pneumonia",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,M(M({},e),{},{icon:K?"folder":"folder-open",color:"blue"}))},onPress:function(){return Q(!K)},children:(0,R.jsxs)(v.default,{children:[(0,R.jsxs)(w.default,{title:"Recommended Regimens",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,M(M({},e),{},{icon:ee?"folder":"folder-open",color:"blue"}))},onPress:function(){return te(!ee)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"erythromycin base, 50 mg/kg body weight/day orally, divided into 4 doses daily for 14 days OR"})}),(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"ethylsuccinate, 50 mg/kg body weight/day orally, divided into 4 doses daily for 14 days"})})]}),(0,R.jsxs)(w.default,{title:"Alternate Regimens",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,M(M({},e),{},{icon:oe?"folder":"folder-open",color:"blue"}))},onPress:function(){return ie(!oe)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"azithromycin suspension 20 mg/kg body weight/ day orally, 1x/day for 3 days"})})]})]})})]})})};function G(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function W(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?G(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):G(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const B=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1],c=a.useState(!0),u=(0,o.default)(c,2),h=u[0],m=u[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options",children:[(0,R.jsxs)(w.default,{title:"For acute epididymitis most likely caused by sexually transmitted chlamydia and gonorrhea",titleNumberOfLines:3,left:function(e){return(0,R.jsx)(T.default,W(W({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{style:N.accordionText,children:["ceftriaxone 500 mg IM in a single dose",(0,R.jsx)(f.default,{style:{fontSize:8,lineHeight:8,backgroundColor:"skyblue"},children:"6"})," PLUS"]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"doxycycline 100 mg orally 2x/day for 10 days"})})]}),(0,R.jsxs)(w.default,{title:"For acute epididymitis most likely caused by chlamydia, gonorrhea, or enteric organisms (men who practice insertive anal sex)",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,W(W({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{style:N.accordionText,children:["ceftriaxone 500 mg IM in a single dose",(0,R.jsx)(f.default,{style:{fontSize:8,lineHeight:8,backgroundColor:"skyblue"},children:"6"})," PLUS"]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"levofloxacin 500 mg orally 1x/day for 10 days"})})]}),(0,R.jsxs)(w.default,{title:"For acute epididymitis most likely caused by enteric organisms only",titleNumberOfLines:3,left:function(e){return(0,R.jsx)(T.default,W(W({},e),{},{icon:h?"folder":"folder-open",color:"blue"}))},onPress:function(){return m(!h)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"levofloxacin 500 mg orally 1x/day for 10 days days"})})]})]})})};function H(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function U(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?H(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):H(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const _=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1],c=a.useState(!0),u=(0,o.default)(c,2),h=u[0],m=u[1],x=a.useState(!0),p=(0,o.default)(x,2),b=p[0],g=p[1],j=a.useState(!0),S=(0,o.default)(j,2),P=S[0],C=S[1],D=a.useState(!0),I=(0,o.default)(D,2),A=I[0],E=I[1],z=a.useState(!0),k=(0,o.default)(z,2),M=k[0],V=k[1],G=a.useState(!0),W=(0,o.default)(G,2),B=W[0],H=W[1],_=a.useState(!0),F=(0,o.default)(_,2),Y=F[0],q=F[1],J=a.useState(!0),Z=(0,o.default)(J,2),K=Z[0],Q=Z[1],X=a.useState(!0),$=(0,o.default)(X,2),ee=$[0],te=$[1],ne=a.useState(!0),re=(0,o.default)(ne,2),oe=re[0],ie=re[1],le=a.useState(!0),ae=(0,o.default)(le,2),se=ae[0],de=ae[1],ce=a.useState(!0),ue=(0,o.default)(ce,2),fe=ue[0],he=ue[1],me=function(){return Q(!K)};return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options",children:[(0,R.jsx)(w.default,{title:"Uncomplicated infections of the cervix, urethra, and rectum: adults and adolescents <150 kg (see note 6)",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:(0,R.jsxs)(v.default,{children:[(0,R.jsxs)(w.default,{title:"Recommended Regimens",left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{style:{flexDirection:"row",alignItems:"flex-start"},children:(0,R.jsxs)(f.default,{style:N.accordionText,children:["ceftriaxone 500 mg IM in a single dose",(0,R.jsx)(f.default,{style:{fontSize:8,lineHeight:8,backgroundColor:"skyblue"},children:" 17"})]})})]}),(0,R.jsxs)(w.default,{title:"Alternate Regimens",left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:h?"folder":"folder-open",color:"blue"}))},onPress:function(){return m(!h)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"If cephalosporin allergy: gentamicin 240 mg IM in a single dose PLUS azithromycin 2 gm orally in a single dose"})}),(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{style:{flexDirection:"row",alignItems:"flex-start"},children:(0,R.jsxs)(f.default,{style:N.accordionText,children:["If ceftriaxone administration is not available or not feasible: cefixime 800 mg orally in a single dose",(0,R.jsx)(f.default,{style:{fontSize:8,lineHeight:8},children:" 17"})]})})]})]})}),(0,R.jsxs)(w.default,{title:"Uncomplicated infection of the pharynx: adults and adolescents <150 kg (see note 6)",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:b?"folder":"folder-open",color:"blue"}))},onPress:function(){return g(!b)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{style:{flexDirection:"row",alignItems:"flex-start"},children:(0,R.jsxs)(f.default,{style:N.accordionText,children:["ceftriaxone 500 mg IM in a single dose",(0,R.jsx)(f.default,{style:{fontSize:8,lineHeight:8},children:" 17"})]})})]}),(0,R.jsxs)(w.default,{title:"Pregnancy",left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:P?"folder":"folder-open",color:"blue"}))},onPress:function(){return C(!P)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{style:{flexDirection:"row",alignItems:"flex-start"},children:(0,R.jsxs)(f.default,{style:N.accordionText,children:["ceftriaxone 500 mg IM in a single dose",(0,R.jsx)(f.default,{style:{fontSize:8,lineHeight:8},children:" 17"})]})})]}),(0,R.jsxs)(w.default,{title:"Conjunctivitis",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:A?"folder":"folder-open",color:"blue"}))},onPress:function(){return E(!A)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{style:{flexDirection:"row",alignItems:"flex-start"},children:(0,R.jsxs)(f.default,{style:N.accordionText,children:["ceftriaxone 1 gm IM in a single dose",(0,R.jsx)(f.default,{style:{fontSize:8,lineHeight:8},children:" 18"})]})})]}),(0,R.jsx)(w.default,{title:"Disseminated gonococcal infections (DGI) (see note 19)",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:M?"folder":"folder-open",color:"blue"}))},onPress:function(){return V(!M)},children:(0,R.jsxs)(v.default,{children:[(0,R.jsxs)(w.default,{title:"Recommended Regimens",left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:B?"folder":"folder-open",color:"blue"}))},onPress:function(){return H(!B)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{style:{flexDirection:"row",alignItems:"flex-start"},children:(0,R.jsxs)(f.default,{style:N.accordionText,children:["ceftriaxone 1 gm IM or by IV every 24 hours",(0,R.jsx)(f.default,{style:{fontSize:8,lineHeight:8},children:" 17"})," OR"]})})]}),(0,R.jsxs)(w.default,{title:"Alternate Regimens",left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:Y?"folder":"folder-open",color:"blue"}))},onPress:function(){return q(!Y)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"cefotaxime 1 gm by IV every 8 hours OR"})}),(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{style:N.accordionText,children:"ceftizoxime 1 gm every 8 hours"})})]})]})}),(0,R.jsxs)(w.default,{title:"Uncomplicated gonococcal vulvovaginitis, cervicitis, urethritis, pharyngitis, or proctitis: children \u226445 kg",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:K?"folder":"folder-open",color:"blue"}))},onPress:me,children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"ceftriaxone 25\u201350 mg/kg body weight by IV or IM in a single dose, not to exceed 250 mg IM"})})]}),(0,R.jsxs)(w.default,{title:"Uncomplicated gonococcal vulvovaginitis, cervicitis, urethritis, pharyngitis, or proctitis: children >45 kg",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:K?"folder":"folder-open",color:"blue"}))},onPress:me,children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Treat with the regimen recommended for adults (see above)"})})]}),(0,R.jsxs)(w.default,{title:"Ocular prophylaxis in neonates",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:ee?"folder":"folder-open",color:"blue"}))},onPress:function(){return te(!ee)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"erythromycin (0.5%) ophthalmic ointment in each eye in a single application at birth"})})]}),(0,R.jsx)(w.default,{title:"Ophthalmia in neonates and infants",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:oe?"folder":"folder-open",color:"blue"}))},onPress:function(){return ie(!oe)},children:(0,R.jsxs)(v.default,{children:[(0,R.jsxs)(w.default,{title:"Recommended Regimens",left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:se?"folder":"folder-open",color:"blue"}))},onPress:function(){return de(!se)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"ceftriaxone 25\u201350 mg/kg body weight by IV OR"})}),(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"IM in a single dose, not to exceed 250 mg"})})]}),(0,R.jsxs)(w.default,{title:"Alternate Regimens",left:function(e){return(0,R.jsx)(T.default,U(U({},e),{},{icon:fe?"folder":"folder-open",color:"blue"}))},onPress:function(){return he(!fe)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"For neonates unable to receive ceftriaxone due to simultaneous administration of intravenous calcium: cefotaxime 100 mg/kg body weight by IV or IM as a single dose"})})]})]})})]})})};function F(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function Y(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?F(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):F(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const q=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1],c=a.useState(!0),u=(0,o.default)(c,2),h=u[0],m=u[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options",children:[(0,R.jsxs)(w.default,{title:"External anogenital warts (see note 12) ",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,Y(Y({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["Patient-applied imiquimod 3.75% or 5% cream",(0,R.jsx)(f.default,{style:{fontSize:8,lineHeight:8,backgroundColor:"skyblue"},children:"13"}),(0,R.jsx)(f.default,{children:" OR"})]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"podofilox 0.5% solution or gel OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["sinecatechins 15% ointment",(0,R.jsx)(f.default,{style:{fontSize:8,lineHeight:8,backgroundColor:"skyblue"},children:"13"}),(0,R.jsx)(f.default,{children:" OR"})]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Provider\u2013administered cryotherapy with liquid nitrogen or cryoprobe OR"})}),(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"surgical removal either by tangential scissor excision, tangential shave excision, curettage, laser, or electrosurgery OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"trichloroacetic acid (TCA) or bichloroacetic acid (BCA) 80%\u201390% solution"})})]}),(0,R.jsxs)(w.default,{title:"Urethral meatus warts ",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,Y(Y({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"cryotherapy with liquid nitrogen OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"surgical removal"})})]}),(0,R.jsxs)(w.default,{title:"Vaginal warts (see note 14), Cervical warts (see note 15), Intra-anal warts (see note 16) ",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,Y(Y({},e),{},{icon:h?"folder":"folder-open",color:"blue"}))},onPress:function(){return m(!h)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"cryotherapy with liquid nitrogen OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"surgical removal OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"TCA or BCA 80%\u201390% solution"})})]})]})})};function J(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function Z(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?J(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):J(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const K=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1],c=a.useState(!0),u=(0,o.default)(c,2),h=u[0],m=u[1],x=a.useState(!0),p=(0,o.default)(x,2),b=p[0],g=p[1],j=a.useState(!0),S=(0,o.default)(j,2),P=S[0],C=S[1],D=a.useState(!0),I=(0,o.default)(D,2),A=I[0],E=I[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options",children:[(0,R.jsxs)(w.default,{title:"First clinical episode of genital herpes (see note 7)",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,Z(Z({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{style:{flexDirection:"row",alignItems:"flex-start"},children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["acyclovir 400 mg orally 3x/day for 7\u201310 days",(0,R.jsx)(f.default,{style:N.superscript,children:"8"})," OR"]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"famciclovir 250 mg orally 3x/day for 7\u201310 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"valacyclovir 1 gm orally 2x/day for 7\u201310 days"})})]}),(0,R.jsxs)(w.default,{title:"Suppressive therapy for recurrent genital herpes (HSV-2) ",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,Z(Z({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"acyclovir 400 mg orally 2x/day OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{style:{flexDirection:"row",alignItems:"flex-start"},children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["valacyclovir 500 mg orally 1x/day",(0,R.jsx)(f.default,{style:N.superscript,children:"9"})," OR"]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"valacyclovir 1 gm orally 1x/day OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"famciclovir 250 mg orally 2x/day"})})]}),(0,R.jsxs)(w.default,{title:"Episodic therapy for recurrent genital herpes (HSV-2)(see note 10) ",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,Z(Z({},e),{},{icon:h?"folder":"folder-open",color:"blue"}))},onPress:function(){return m(!h)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"acyclovir 800 mg orally 2x/day for 5 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"acyclovir 800 mg orally 3x/day for 2 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"famciclovir 1 gm orally 2x/day for 1 day OR"})}),(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"famciclovir 500 mg once, FOLLOWED BY 250 mg 2x/day for 2 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"famciclovir 125 mg 2x/day for 5 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"valacyclovir 500 mg orally 2x/day for 3 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"valacyclovir 1 gm orally 1x/day for 5 days"})})]}),(0,R.jsxs)(w.default,{title:"Daily suppressive therapy for persons with HIV infection ",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,Z(Z({},e),{},{icon:b?"folder":"folder-open",color:"blue"}))},onPress:function(){return g(!b)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"acyclovir 400-800 mg orally 2x\u20133x/day OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"famciclovir 500 mg orally 2x/day OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"valacyclovir 500 mg orally 2x/day"})})]}),(0,R.jsxs)(w.default,{title:"Episodic therapy for persons with HIV infection",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,Z(Z({},e),{},{icon:P?"folder":"folder-open",color:"blue"}))},onPress:function(){return C(!P)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"acyclovir 400 mg orally 3x/day for 5\u201310 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"famciclovir 500 mg orally 2x/day for 5\u201310 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"valacyclovir 1 gm orally 2x/day for 5\u201310 days"})})]}),(0,R.jsxs)(w.default,{title:"Daily suppressive therapy of recurrent genital herpes in pregnant women (see note 11)",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,Z(Z({},e),{},{icon:A?"folder":"folder-open",color:"blue"}))},onPress:function(){return E(!A)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"acyclovir 400 mg orally 3x/day OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"valacyclovir 500 mg orally 2x/day"})})]})]})})};var Q=n(6459);const X=function(e){return(0,Q.default)(e),(0,R.jsx)(y.default,{style:{flex:1,fontWeight:"bold",fontSize:22},children:(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{style:N.baseText2,children:["A63.8 Other specified predominantly sexually transmitted diseases","\n","\n","A64 Unspecified sexually transmitted disease","\n","\n","N89.8  Other specified noninflammatory disorders of vagina","\n","\n","Z11.3  Encounter for screening for infections with a predominantly sexual mode of transmission","\n","\n","Z20.2 Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission","\n","\n","Z20.9 Contact with and (suspected) exposure to unspecified communicable disease","\n","\n","Z77.9 Other contact with and (suspected) exposures hazardous to health","\n","\n","A49.3 Mycoplasma infection, unspecified site","\n","\n","A49.9  Bacterial infection, unspecified","\n","\n","B37.3 Candidiasis of vulva and vagina","\n","\n","B37.9 Candidiasis, unspecified","\n","\n","A56.02 Chlamydia trachomatis infection of lower genitourinary sites","\n","\n","A74.89 Other chlamydial diseases","\n","\n","A74.9  Chlamydial infection, unspecified","\n","\n","A60.04 Herpesviral vulvovaginitis","\n","\n","A63.0 Anogenital (venereal) warts","\n","\n","B00.89 Other herpes viral infection","\n","\n","B07.9 Viral wart, unspecified","\n","\n","N76.4  Abcess of vulva","\n","\n","A49.3  Mycoplasma infection, unspecified site","\n","\n","A59.01 Trichomonal vulvovaginitis","\n","\n","A59.9 Trichomoniasis, unspecified"]})})})})};function $(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function ee(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?$(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):$(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const te=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options",children:[(0,R.jsxs)(w.default,{title:"Recommended Regimen",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,ee(ee({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"doxycycline 100 mg orally 2x/day for 21 days"})})]}),(0,R.jsxs)(w.default,{title:"Alternate Regimens",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,ee(ee({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:[" azithromycin 1 gm orally 1x/week for 3 weeks ",(0,R.jsx)(f.default,{style:{fontSize:8,lineHeight:8},children:" 20"})," OR"]})}),(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"erythromycin base 500 mg orally 4x/day for 21 days"})})]})]})})};var ne=n(5722);const re=function(e){return(0,Q.default)(e),(0,R.jsx)(y.default,{style:{flex:1,fontWeight:"bold",fontSize:22},children:(0,R.jsxs)(O.default,{style:N.scrollView,children:[(0,R.jsxs)(f.default,{style:N.baseText,children:["Medical Diagnostic Laboratories, L.L.C. (MDL), founded in 1997, serves primarily as a reference laboratory for Polymerase Chain Reaction (PCR) based testing to physicians, laboratories and hospitals worldwide. MDL is a CLIA certified infectious disease laboratory with multiple state licenses specializing in PCR technology. Molecular diagnostic techniques, such as the PCR method, are considered to be the most sensitive and specific for the laboratory diagnosis of infectious diseases. MDL offers unique, non-invasive, highly stable specimen collection and transport platforms, such as the ",(0,R.jsx)(f.default,{style:N.innerTextred,children:"One"}),"Swab,",(0,R.jsx)(f.default,{style:N.innerTextyellow,children:" Uro"}),"Swab and ",(0,R.jsx)(f.default,{style:N.innerTextgreen,children:"Naso"}),"Swab These platforms enable MDL to offer a variety of PCR based tests from a single swab with high sensitivity and specificity"]}),(0,R.jsxs)(y.default,{children:[(0,R.jsx)(f.default,{style:{textAlign:"center"},children:" click below to go to MDLAB.com"}),(0,R.jsx)(h.default,{onPress:function(){return ne.default.openURL("https://www.mdlab.com")},style:N.MDLPic,children:(0,R.jsx)("img",{style:{flex:1},src:n(3648)})}),(0,R.jsx)(f.default,{style:{textAlign:"center"},children:"2439 Kuser Road . Hamilton NJ 08690-3303 www.mdlab.com . Toll Free 877-269-0090"})]})]})})};function oe(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function ie(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?oe(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):oe(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const le=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1],c=a.useState(!0),u=(0,o.default)(c,2),h=u[0],m=u[1],x=a.useState(!0),p=(0,o.default)(x,2),b=p[0],g=p[1],j=a.useState(!0),S=(0,o.default)(j,2),P=S[0],C=S[1],D=a.useState(!0),I=(0,o.default)(D,2),A=I[0],E=I[1],z=a.useState(!0),k=(0,o.default)(z,2),M=k[0],V=k[1],G=a.useState(!0),W=(0,o.default)(G,2),B=W[0],H=W[1],U=a.useState(!0),_=(0,o.default)(U,2),F=_[0],Y=_[1],q=a.useState(!0),J=(0,o.default)(q,2),Z=J[0],K=J[1],Q=a.useState(!0),X=(0,o.default)(Q,2),$=X[0],ee=X[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options",children:[(0,R.jsxs)(w.default,{title:"Non Recurent Recommendations",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,ie(ie({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsxs)(w.default,{title:"Recommended Regimen",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,ie(ie({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"doxycycline 100 mg orally 2x/day for 7 days"})})]}),(0,R.jsxs)(w.default,{title:"Alternate Regimens",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,ie(ie({},e),{},{icon:h?"folder":"folder-open",color:"blue"}))},onPress:function(){return m(!h)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"azithromycin 1 gm orally in a single dose OR"})}),(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"azithromycin 500 mg orally in a single dose, THEN 250 mg 1x/day for 4 days"})})]})]}),(0,R.jsxs)(w.default,{title:"Persistent or Recurrent NGU: test for Mycoplasma genitalium:",titleNumberOfLines:5,left:function(e){return(0,R.jsx)(T.default,ie(ie({},e),{},{icon:b?"folder":"folder-open",color:"blue"}))},onPress:function(){return g(!b)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsxs)(w.default,{title:"If M. genitalium resistance testing is unavailable but M. genitalium is detected by an FDA-cleared NAAT ",titleNumberOfLines:7,left:function(e){return(0,R.jsx)(T.default,ie(ie({},e),{},{icon:P?"folder":"folder-open",color:"blue"}))},onPress:function(){return C(!P)},children:[(0,R.jsxs)(w.default,{title:"Recommended Regimen",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,ie(ie({},e),{},{icon:A?"folder":"folder-open",color:"blue"}))},onPress:function(){return E(!A)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"doxycycline 100 mg orally 2x/day for 7 days, FOLLOWED BY moxifloxacin 400 mg 1x/day for 7 days"})})]}),(0,R.jsxs)(w.default,{title:"Alternate Regimens",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,ie(ie({},e),{},{icon:M?"folder":"folder-open",color:"blue"}))},onPress:function(){return V(!M)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:" For settings without resistance testing and when moxifloxacin cannot be used: doxycycline 100 mg orally 2x/day for 7 days, FOLLOWED BY azithromycin 1 gm orally on first day, FOLLOWED BY azithromycin 500 mg orally 1x/day for 3 days and a test-of-cure 21 days after completion of therapy"})})]})]}),(0,R.jsx)(w.default,{title:"If resistance testing is available, use resistance-guided therapy ",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,ie(ie({},e),{},{icon:B?"folder":"folder-open",color:"blue"}))},onPress:function(){return H(!B)},children:(0,R.jsxs)(w.default,{title:"Recommended Regimen",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,ie(ie({},e),{},{icon:F?"folder":"folder-open",color:"blue"}))},onPress:function(){return Y(!F)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["Macrolide sensitive doxycycline 100 mg orally 2x/day for 7 days, FOLLOWED BY azithromycin 1 gm orally initial dose, FOLLOWED BY azithromycin 500 mg orally 1x/day for 3 additional days (2.5 gm total)","\n","\n","Macrolide resistance doxycycline 100 mg orally 2x/day for 7 days, FOLLOWED BY moxifloxacin 400 mg orally 1x/day for 7 days"]})})]})}),(0,R.jsx)(w.default,{title:"Test for Trichomonas vaginalis in heterosexual men in areas where infection is prevalent ",titleNumberOfLines:7,left:function(e){return(0,R.jsx)(T.default,ie(ie({},e),{},{icon:Z?"folder":"folder-open",color:"blue"}))},onPress:function(){return K(!Z)},children:(0,R.jsxs)(w.default,{title:"Recommended Regimen",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,ie(ie({},e),{},{icon:$?"folder":"folder-open",color:"blue"}))},onPress:function(){return ee(!$)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"metronidazole 2 gm orally in a single dose OR tinidazole 2 gm orally in a single dose"})})]})})]})]})})};function ae(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function se(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?ae(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):ae(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const de=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1],c=a.useState(!0),u=(0,o.default)(c,2),h=u[0],m=u[1],x=a.useState(!0),p=(0,o.default)(x,2),b=p[0],g=p[1],j=a.useState(!0),S=(0,o.default)(j,2),P=S[0],C=S[1],D=a.useState(!0),I=(0,o.default)(D,2),A=I[0],E=I[1],z=a.useState(!0),k=(0,o.default)(z,2),M=k[0],V=k[1],G=a.useState(!0),W=(0,o.default)(G,2),B=W[0],H=W[1],U=a.useState(!0),_=(0,o.default)(U,2),F=_[0],Y=_[1],q=a.useState(!0),J=(0,o.default)(q,2),Z=J[0],K=J[1],Q=a.useState(!0),X=(0,o.default)(Q,2),$=X[0],ee=X[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options",children:[(0,R.jsxs)(w.default,{title:"Non Recurent Recommendations",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,se(se({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsxs)(w.default,{title:"Recommended Regimen",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,se(se({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"doxycycline 100 mg orally 2x/day for 7 days"})})]}),(0,R.jsxs)(w.default,{title:"Alternate Regimens",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,se(se({},e),{},{icon:h?"folder":"folder-open",color:"blue"}))},onPress:function(){return m(!h)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"azithromycin 1 gm orally in a single dose OR"})}),(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"azithromycin 500 mg orally in a single dose, THEN 250 mg 1x/day for 4 days"})})]})]}),(0,R.jsxs)(w.default,{title:"Persistent or Recurrent NGU: test for Mycoplasma genitalium:",titleNumberOfLines:5,left:function(e){return(0,R.jsx)(T.default,se(se({},e),{},{icon:b?"folder":"folder-open",color:"blue"}))},onPress:function(){return g(!b)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsxs)(w.default,{title:"If M. genitalium resistance testing is unavailable but M. genitalium is detected by an FDA-cleared NAAT ",titleNumberOfLines:7,left:function(e){return(0,R.jsx)(T.default,se(se({},e),{},{icon:P?"folder":"folder-open",color:"blue"}))},onPress:function(){return C(!P)},children:[(0,R.jsxs)(w.default,{title:"Recommended Regimen",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,se(se({},e),{},{icon:A?"folder":"folder-open",color:"blue"}))},onPress:function(){return E(!A)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"doxycycline 100 mg orally 2x/day for 7 days, FOLLOWED BY moxifloxacin 400 mg 1x/day for 7 days"})})]}),(0,R.jsxs)(w.default,{title:"Alternate Regimens",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,se(se({},e),{},{icon:M?"folder":"folder-open",color:"blue"}))},onPress:function(){return V(!M)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:" For settings without resistance testing and when moxifloxacin cannot be used: doxycycline 100 mg orally 2x/day for 7 days, FOLLOWED BY azithromycin 1 gm orally on first day, FOLLOWED BY azithromycin 500 mg orally 1x/day for 3 days and a test-of-cure 21 days after completion of therapy"})})]})]}),(0,R.jsx)(w.default,{title:"If resistance testing is available, use resistance-guided therapy ",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,se(se({},e),{},{icon:B?"folder":"folder-open",color:"blue"}))},onPress:function(){return H(!B)},children:(0,R.jsxs)(w.default,{title:"Recommended Regimen",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,se(se({},e),{},{icon:F?"folder":"folder-open",color:"blue"}))},onPress:function(){return Y(!F)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["Macrolide sensitive doxycycline 100 mg orally 2x/day for 7 days, FOLLOWED BY azithromycin 1 gm orally initial dose, FOLLOWED BY azithromycin 500 mg orally 1x/day for 3 additional days (2.5 gm total)","\n","\n","Macrolide resistance doxycycline 100 mg orally 2x/day for 7 days, FOLLOWED BY moxifloxacin 400 mg orally 1x/day for 7 days"]})})]})}),(0,R.jsx)(w.default,{title:"Test for Trichomonas vaginalis in heterosexual men in areas where infection is prevalent ",titleNumberOfLines:7,left:function(e){return(0,R.jsx)(T.default,se(se({},e),{},{icon:Z?"folder":"folder-open",color:"blue"}))},onPress:function(){return K(!Z)},children:(0,R.jsxs)(w.default,{title:"Recommended Regimen",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,se(se({},e),{},{icon:$?"folder":"folder-open",color:"blue"}))},onPress:function(){return ee(!$)},children:[(0,R.jsx)(L.default,{NumberOfLines:4}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"metronidazole 2 gm orally in a single dose OR tinidazole 2 gm orally in a single dose"})})]})})]})]})})};function ce(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function ue(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?ce(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):ce(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const fe=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options",children:[(0,R.jsxs)(w.default,{title:"Recommended Regimens for initial therapy",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,ue(ue({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:[(0,R.jsx)(L.default,{}),(0,R.jsxs)(y.default,{children:[(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["Kanamycin",(0,R.jsx)(f.default,{style:N.superscript,children:"26"})," ovules 100mg (corresponding to 83 mg of active compound) 1 ovule per day for 6 days OR"]}),(0,R.jsx)(L.default,{}),(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["Clindamycin",(0,R.jsx)(f.default,{style:N.superscript,children:"26"})," 2% topical cream 4 to 5 g daily for 4 to 6 weeks OR"]}),(0,R.jsx)(L.default,{}),(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["Clindamycin",(0,R.jsx)(f.default,{style:N.superscript,children:"26"})," 2% topical cream 5 g daily with hydrocortisone 300 mg to 500 mg for 7 to 21 days OR"]}),(0,R.jsx)(L.default,{}),(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["Moxifloxacin",(0,R.jsx)(f.default,{style:N.superscript,children:"26"})," 400 mg q.d. for 6 days"]})]}),(0,R.jsx)(L.default,{})]}),(0,R.jsx)(f.default,{style:N.innerTextred,children:"The CDC does not provide treatment guidelines for Aerobic vaginitis (AV); Therefore, separate references are cited for each guideline."})]})})};function he(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function me(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?he(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):he(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const ye=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1],c=a.useState(!0),u=(0,o.default)(c,2),h=u[0],m=u[1],x=a.useState(!0),p=(0,o.default)(x,2),b=p[0],g=p[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options",children:[(0,R.jsxs)(w.default,{title:"Parenteral treatment",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,me(me({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:[(0,R.jsxs)(w.default,{title:"RECOMMENDED REGIMEN",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,me(me({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"ceftriaxone 1 gm by IV every 24 hours PLUS doxycycline 100 mg orally or by IV every 12 hours PLUS metronidazole 500 mg orally or by IV every 12 hours OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"cefotetan 2 gm by IV every 12 hours PLUS doxycycline 100 mg orally or by IV every 12 hours OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"cefoxitin 2 gm by IV every 6 hours PLUS doxycycline 100 mg orally or by IV every 12 hours"})})]}),(0,R.jsxs)(w.default,{title:"ALTERNATE REGIMEN",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,me(me({},e),{},{icon:h?"folder":"folder-open",color:"blue"}))},onPress:function(){return m(!h)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"ampicillin-sulbactam 3 gm by IV every 6 hours PLUS doxycycline 100 mg orally or by IV every 12 hours OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"clindamycin 900 mg by IV every 8 hours PLUS gentamicin 2 mg/kg body weight by IV or IM FOLLOWED BY 1.5 mg/kg body weight every 8 hours. Can substitute with 3\u20135 mg/kg body weight 1x/day"})})]})]}),(0,R.jsxs)(w.default,{title:"Intramuscular or oral treatment",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,me(me({},e),{},{icon:b?"folder":"folder-open",color:"blue"}))},onPress:function(){return g(!b)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["ceftriaxone 500 mg IM in a single dose",(0,R.jsx)(f.default,{style:{fontSize:8,lineHeight:8},children:" 6"})," PLUS doxycycline 100 mg orally 2x/day for 14 days WITH metronidazole 500 mg orally 2x/day for 14 days OR"]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"cefoxitin 2 gm IM in a single dose AND probenecid 1 gm orally, administered concurrently in a single dose PLUS doxycycline 100 mg orally 2x/day for 14 days WITH metronidazole 500 mg orally 2x/day for 14 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Other parenteral third-generation cephalosporin (e.g., ceftizoxime or cefotaxime) PLUS doxycycline 100 mg orally 2x/day for 14 days WITH metronidazole 500 mg orally 2x/day for 14 days"})})]}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,children:["\n","\n","The complete list of recommended regimens can be found in Sexually Transmitted Infections Treatment Guidelines, 2021."]})})]})})};function xe(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function pe(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?xe(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):xe(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const be=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1],c=a.useState(!0),u=(0,o.default)(c,2),h=u[0],m=u[1],x=a.useState(!0),p=(0,o.default)(x,2),b=p[0],g=p[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options",children:[(0,R.jsxs)(w.default,{title:"RECOMMENDED REGIMEN Over-the-Counter Intravaginal Agents",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,pe(pe({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Clotrimazole 1% cream 5 g intravaginally daily for 7\u201314 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Clotrimazole 2% cream 5 g intravaginally daily for 3 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Miconazole 2% cream 5 g intravaginally daily for 7 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Miconazole 4% cream 5 g intravaginally for 3 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Miconazole 100 mg vaginal suppository, one suppository for 7 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Miconazole 200 mg vaginal suppository, one suppository for 3 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Miconazole 1,200 mg vaginal suppository, one suppository for 1 day OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Tioconazole 6.5% ointment 5 g intravaginally in a single application"})})]}),(0,R.jsxs)(w.default,{title:"Prescription Intravaginal Agents",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,pe(pe({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Butoconazole 2% cream (single dose bioadhesive product), 5 g intravaginally in a single application OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Terconazole 0.4% cream 5 g intravaginally for 7 days OR"})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Terconazole 0.8% cream 5 g intravaginally for 3 days OR"})}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Terconazole 80 mg vaginal suppository, one suppository daily for 3 days"})})]}),(0,R.jsxs)(w.default,{title:"Oral Agent",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,pe(pe({},e),{},{icon:h?"folder":"folder-open",color:"blue"}))},onPress:function(){return m(!h)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"Fluconazole 150 mg orally in a single dose"})})]}),(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.baseText,children:["\n","\n","Short-course topical formulations (i.e., single dose and regimens of 1\u20133 days) effectively treat uncomplicated VVC. The topically applied azole drugs are more effective than nystatin. Treatment with azoles results in relief of symptoms and negative cultures in 80%\u201390% of patients who complete therapy."]}),(0,R.jsx)(f.default,{style:N.innerTextred,children:"The creams and suppositories in this regimen are oil-based and might weaken latex condoms and diaphragms.  Patients and providers should refer to condom product labeling for further information. "}),(0,R.jsxs)(w.default,{title:"Special Considerations",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,pe(pe({},e),{},{icon:b?"folder":"folder-open",color:"blue"}))},onPress:function(){return g(!b)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["Recurrent Vulvovaginal Candidiasis (RVVC)","\n","\n","RVVC, usually defined as three or more episodes of symptomatic VVC in less than 1 year, affects a small percentage of women (less than 5%). C. glabrata and other non-albicans Candida species are observed in 10%\u201320% of patients with RVVC. Conventional antimycotic therapies are not as effective against these species as against C. albicans."]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["RVVC Treatment","\n","\n","Some specialists recommend a longer duration of initial therapy e.g., 7\u201314 days of topical therapy or a 100 mg, 150 mg, or 200 mg oral dose of fluconazole every third day for a total of 3 doses (day 1, 4, and 7) to attempt mycologic remission before initiating a maintenance antifungal regimen."]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["Maintenance Regimens","\n","\n","Oral fluconazole (i.e., 100 mg, 150 mg or 200 mg dose) weekly for 6 months is the first line maintenance regimen. If this regimen is not feasible, topical treatments used intermittently can also be considered. Suppressive maintenance therapies are effective in reducing RVVC. However, 30%\u201350% of women will have recurrent disease after maintenance therapy is discontinued. Symptomatic women who remain culture positive despite maintenance therapy should be managed in consultation with a specialist."]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["Severe VVC","\n","\n","Severe vulvovaginitis (i.e., extensive vulvar erythema, edema, excoriation, and fissure formation) is associated with lower clinical response rates in patients treated with short courses of topical or oral therapy. Either 7\u201314 days of topical azole or 150 mg of fluconazole in two sequential doses (second dose 72 hours after initial dose) is recommended."]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["Non-albicans VVC","\n","\n","Options include longer duration of therapy (7\u201314 days) with a nonfluconazole azole drug (oral or topical) as first-line therapy. If recurrence occurs, 600 mg of boric acid in a gelatin capsule is recommended, administered vaginally once daily for 3 weeks. If symptoms recur, referral to a specialist is advised."]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["Pregnancy","\n","\n","VVC frequently occurs during pregnancy. Only topical azole therapies, applied for 7 days, are recommended for use among pregnant women."]})}),(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsxs)(f.default,{NumberOfLines:4,style:N.accordionText,children:["Compromised Host","\n","\n","Treatment for women with HIV infection and uncomplicated or complicated VVC should not differ from that for women who do not have HIV, except where long-term prophylactic therapy with fluconazole (i.e., 200mg weekly) should only be considered for women with HIV and complicated VVC."]})})]})]})})};function ge(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function je(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?ge(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):ge(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const Oe=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1],c=a.useState(!0),u=(0,o.default)(c,2),h=u[0],m=u[1],x=a.useState(!0),p=(0,o.default)(x,2),b=p[0],g=p[1],j=a.useState(!0),S=(0,o.default)(j,2),P=S[0],C=S[1],D=a.useState(!0),I=(0,o.default)(D,2),A=I[0],E=I[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options",children:[(0,R.jsxs)(w.default,{title:"Primary, secondary, and early latent: adults (including pregnant women and people with HIV infection)",titleNumberOfLines:7,left:function(e){return(0,R.jsx)(T.default,je(je({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"benzathine penicillin G 2.4 million units IM in a single dose"})})]}),(0,R.jsxs)(w.default,{title:"Late latent adults (including pregnant women and people with HIV infection)",titleNumberOfLines:7,left:function(e){return(0,R.jsx)(T.default,je(je({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million units IM each at 1-week intervals"})})]}),(0,R.jsxs)(w.default,{title:"Neurosyphilis, ocular syphilis, and otosyphilis ",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,je(je({},e),{},{icon:h?"folder":"folder-open",color:"blue"}))},onPress:function(){return m(!h)},children:[(0,R.jsxs)(w.default,{title:"RECOMMENDED REGIMEN",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,je(je({},e),{},{icon:b?"folder":"folder-open",color:"blue"}))},onPress:function(){return g(!b)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"aqueous crystalline penicillin G 18\u201324 million units per day, administered as 3\u20134 million units by IV every 4 hours or continuous infusion, for 10\u201314 days"})})]}),(0,R.jsxs)(w.default,{title:"ALTERNATE REGIMEN",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,je(je({},e),{},{icon:P?"folder":"folder-open",color:"blue"}))},onPress:function(){return C(!P)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"procaine penicillin G 2.4 million units IM 1x/day PLUS probenecid 500 mg orally 4x/day, both for 10\u201314 days"})})]})]}),(0,R.jsxs)(w.default,{title:"For children or congenital syphilis ",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,je(je({},e),{},{icon:A?"folder":"folder-open",color:"blue"}))},onPress:function(){return E(!A)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"See Sexually Transmitted Infections Treatment Guidelines, 2021."})})]})]})})};function ve(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function we(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?ve(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):ve(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}const Te=function(){var e=a.useState(!0),t=(0,o.default)(e,2),n=t[0],r=t[1],i=a.useState(!0),l=(0,o.default)(i,2),s=l[0],d=l[1],c=a.useState(!0),u=(0,o.default)(c,2),h=u[0],m=u[1],x=a.useState(!0),p=(0,o.default)(x,2),b=p[0],g=p[1],j=a.useState(!0),S=(0,o.default)(j,2),P=S[0],C=S[1],D=a.useState(!0),I=(0,o.default)(D,2),A=I[0],E=I[1];return(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(v.default,{title:"Treatment Options (see note 25)",children:[(0,R.jsxs)(w.default,{title:"Women ",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,we(we({},e),{},{icon:n?"folder":"folder-open",color:"blue"}))},onPress:function(){return r(!n)},children:[(0,R.jsxs)(w.default,{title:"RECOMMENDED REGIMEN",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,we(we({},e),{},{icon:s?"folder":"folder-open",color:"blue"}))},onPress:function(){return d(!s)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"metronidazole 500 mg orally 2x/day for 7 days"})})]}),(0,R.jsxs)(w.default,{title:"ALTERNATE REGIMEN",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,we(we({},e),{},{icon:h?"folder":"folder-open",color:"blue"}))},onPress:function(){return m(!h)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"tinidazole 2 gm orally in a single dose"})})]})]}),(0,R.jsxs)(w.default,{title:"Men ",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,we(we({},e),{},{icon:b?"folder":"folder-open",color:"blue"}))},onPress:function(){return g(!b)},children:[(0,R.jsxs)(w.default,{title:"RECOMMENDED REGIMEN",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,we(we({},e),{},{icon:P?"folder":"folder-open",color:"blue"}))},onPress:function(){return C(!P)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"metronidazole 2 gm orally in a single dose"})})]}),(0,R.jsxs)(w.default,{title:"ALTERNATE REGIMEN",titleNumberOfLines:4,left:function(e){return(0,R.jsx)(T.default,we(we({},e),{},{icon:A?"folder":"folder-open",color:"blue"}))},onPress:function(){return E(!A)},children:[(0,R.jsx)(L.default,{}),(0,R.jsx)(y.default,{children:(0,R.jsx)(f.default,{NumberOfLines:4,style:N.accordionText,children:"tinidazole 2 gm orally in a single dose"})})]})]})]})})};var Le=n(8135),Se=n(8441),Pe=n(6434),Ne=(m.default.get("window").width,(0,j.default)());(0,Le.default)();function Re(e){return(0,Q.default)(e),(0,R.jsx)(Pe.default,{style:{flex:1},imageStyle:{resizeMode:"stretch"},source:n(1429),children:(0,R.jsx)(y.default,{style:N.container,children:(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsx)(y.default,{style:{flex:1,alignItems:"center",justifyContent:"center"}})})})})}const Ce=function(){return(0,R.jsx)(Ne.Navigator,{screenOptions:{headerShown:!1},children:(0,R.jsx)(Ne.Screen,{name:"Home",component:Re})})};const De=function(e){return e.navigation,(0,R.jsx)(y.default,{style:{flex:1,alignItems:"center",justifyContent:"center"},children:(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(f.default,{style:N.baseText2,children:["1. Clindamycin ovules use an oleaginous base that might weaken latex or rubber products (e.g., condoms and diaphragms). Use of such products within 72 hours following treatment with clindamycin ovules is not recommended.","\n","\n","2. Oral granules should be sprinkled onto unsweetened applesauce, yogurt, or pudding before ingestion. A glass of water can be taken after administration to aid in swallowing.","\n","\n","3. Consider concurrent treatment for gonococcal infection if the patient is at risk for gonorrhea or lives in a community where the prevalence of gonorrhea is high (see Gonorrhea section).","\n","\n","4. Data are limited regarding the effectiveness and optimal dose of azithromycin for treating chlamydial infection among infants and children who weigh less than 45 kg.","\n","\n","5. An association between oral erythromycin and azithromycin and infantile hypertrophic pyloric stenosis (IHPS) has been reported among infants aged less than 6 weeks. Infants treated with either of these antimicrobials should be followed for IHPS signs and symptoms.","\n","\n","6. For persons weighing \u2265150 kg, 1 gm ceftriaxone should be administered.","\n","\n","7. Treatment can be extended if healing is incomplete after 10 days of therapy.","\n","\n","8. Acyclovir 200 mg orally five times/day is also effective but is not recommended because of the frequency of dosing.","\n","\n","9. Valacyclovir 500 mg once a day might be less effective than other valacyclovir or acyclovir dosing regimens for persons who have frequent recurrences (i.e., \u226510 episodes/year).","\n","\n","10. Acyclovir 400 mg orally three times/day is also effective but is not recommended because of frequency of dosing.","\n","\n","11. Treatment recommended starting at 36 weeks gestation. (Source: American College of Obstetricians and Gynecologists. Clinical management guidelines for obstetrician-gynecologists. Management of herpes in pregnancy. ACOG Practice Bulletin No. 82. Obstet Gynecol 2007;109:1489\u201398.)","\n","\n","12. Persons with external anal or peri-anal warts might also have intra-anal warts. Thus, persons with external anal warts might benefit from an inspection of the anal canal by digital examination, standard anoscopy, or high-resolution anoscopy.","\n","\n","13. Might weaken condoms and vaginal diaphragms.","\n","\n","14. The use of a cryoprobe in the vagina is not recommended because of the risk for vaginal perforation and fistula formation.","\n","\n","15. Management of cervical warts should include consultation with a specialist. For women who have exophytic cervical warts, a biopsy evaluation to exclude high-grade squamous intraepithelial lesion should be performed before treatment is initiated.","\n","\n","16. Management of intra-anal warts should include consultation with a specialist.","\n","\n","17. If chlamydial infection has not been excluded, treat for chlamydia with doxycycline 100 mg orally two times/day for 7 days (if pregnant, treat with azithromycin 1 gm orally in a single dose).","\n","\n","18. Providers should consider one-time lavage of the infected eye with saline solution.","\n","\n","19. When treating for the arthritis-dermatitis syndrome, the provider can switch to an oral agent guided by antimicrobial susceptibility testing (AST) 24 to 48 hours after substantial clinical improvement, for a total treatment course of less than 7 days.","\n","\n","20. Because this regimen has not been validated rigorously, a test-of-cure with Chlamydia trachomatis nucleic acid amplification test (NAAT) 4 weeks after completion of treatment can be considered. 21. Infants and young children (aged less than 5 years) should be treated with permethrin.","\n","\n","22. Oral ivermectin has limited ovicidal activity; a second dose is required for cure.","\n","\n","23. Infants and children aged less than 10 years should not be treated with lindane.","\n","\n","24. The complete list of recommendations on treating syphilis among people with HIV infection and pregnant women, as well as discussion of alternative therapy in people with penicillin allergy, can be found in Sexually Transmitted Infections Treatment Guidelines, 2021.","\n","\n","25. For management of persistent or recurrent infection, refer to Sexually Transmitted Infections Treatment Guidelines, 2021.","\n","\n","26. Sherrard J, Wilson J, Donders G, Mendling W, Jenson JS. 2018. 2018 European (IUSTI/WHO) International Union against Sexually transmitted infections (IUSTI) World Health Organization (WHO) guideline on the management of vaginal discharge. Intern J STD AIDS 0(0): 1-15.","\n","\n","Accessible version: https://www.cdc.gov/std/treatment-guidelines/default.htm"]})})})};var Ie=n(5671),Ae=n(3144),Ee=n(136),ze=n(2963),ke=n(1120),Me=n(5288),Ve=n(7192),Ge=n(1318);function We(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function Be(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?We(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):We(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}function He(e){var t=function(){if("undefined"===typeof Reflect||!Reflect.construct)return!1;if(Reflect.construct.sham)return!1;if("function"===typeof Proxy)return!0;try{return Boolean.prototype.valueOf.call(Reflect.construct(Boolean,[],(function(){}))),!0}catch(e){return!1}}();return function(){var n,r=(0,ke.default)(e);if(t){var o=(0,ke.default)(this).constructor;n=Reflect.construct(r,arguments,o)}else n=r.apply(this,arguments);return(0,ze.default)(this,n)}}var Ue=function(e){(0,Ee.default)(r,e);var t=He(r);function r(){var e;(0,Ie.default)(this,r);for(var n=arguments.length,o=new Array(n),i=0;i<n;i++)o[i]=arguments[i];return(e=t.call.apply(t,[this].concat(o))).state={screenWidth:null,screenHeight:null},e}return(0,Ae.default)(r,[{key:"_onLayout",value:function(e){console.log("Screen Orientation Changed..."),this.setState({screenWidth:m.default.get("window").width,screenHeight:m.default.get("window").height})}},{key:"render",value:function(){(0,R.jsx)(R.Fragment,{});var e=this.props.navigation,t=this.state,r=t.screenHeight,o=t.screenWidth;return(0,R.jsx)(Pe.default,{style:{flex:1},imageStyle:{resizeMode:"stretch"},source:n(9129),children:(0,R.jsxs)(y.default,{style:r>o?N.ContainerPortrait:N.ContainerLandscape,onLayout:this._onLayout.bind(this),children:[(0,R.jsx)(R.Fragment,{}),(0,R.jsxs)(O.default,{style:N.scrollView,children:[(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("Trichomoniasis")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:r>o?N.buttonText:N.buttonTextLandscape,children:"Trichomonas vaginalis"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("Gonococcal_Infections")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,children:"Neisseria gonorhoeae"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("Chlamydial_Infections")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,children:"Chlamydia trachomatis"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("Lymphogranuloma_Venereum")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,children:"Lymphogranuloma Venereum"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("HSV")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,children:"Genital Herpes Simplex Virus (HSV)"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("Syphilis")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,children:"Treponema pallidum"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("Bacterial_Vaginosis")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,children:"Bacterial Vaginosis"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("Avag")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,children:"Aerobic vaginitis"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("VVC")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,children:"Vulvovaginal candidiasis"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("HPV")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,children:"Human Papillomavirus (HPV)"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("Cervicitis")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,NumberOfLines:2,children:"Cervicitis"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("Mgent")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,children:"Mycoplasma genitalium"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("Pelvic_Inflammatory_Disease")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,children:"Pelvic Inflammatory Disease"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("Nongonococcal_Urethritis")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,children:"Nongonococcal Urethritis (NGU)"})})})}),(0,R.jsx)(Me.default,{onPress:function(){return e.navigate("Epididymitis")},children:(0,R.jsx)(y.default,{style:r>o?N.button:N.buttonLandscape,onLayout:this._onLayout.bind(this),children:(0,R.jsx)(Ve.AutoSizeText,{fontSize:20,numberOfLines:2,mode:Ve.ResizeTextMode.max_lines,children:(0,R.jsx)(f.default,{style:N.buttonText,children:"Epididymitis"})})})})]})]})})}}]),r}(a.Component);function _e(e){var t=(0,Ge.useNavigation)();return(0,R.jsx)(Ue,Be(Be({},e),{},{navigation:t}))}const Fe=function(e){return e.navigation,(0,R.jsx)(y.default,{style:{flex:1,alignItems:"center",justifyContent:"center"},children:(0,R.jsx)(O.default,{style:N.scrollView,children:(0,R.jsxs)(f.default,{style:N.baseText2,children:["Terms And Conditions Of Use Acceptance of Terms and Conditions of Use","\n","\n","By downloading this mobile application (\u201cApp\u201d) from Genesis Biotechnology Group, LLC (\u201cGBG\u201d), you affirm that you are legally competent to accept and agree to the Terms and Conditions (\u201cTerms\u201d). If you do not agree to any of the terms, then do not download this App.","\n","\n","The Terms constitute an agreement between GBG and its affiliates (collectively, \u201cGBG\u201d or \u201cwe\u201d or \u201cus\u201d) and you. We recommend that you print out a copy of the Terms for your records.","\n","\n","Disclaimer","\n","\n","The content contained in the App has been obtained from the Centers for Disease Control and Prevention\u2019s (CDC) 2021 STD Treatment Guidelines. By visiting https://www.cdc.gov/std/treatment-guidelines/default.htm, you may access the CDC\u2019s entire 2021 STD Treatment Guidelines for your reference. GBG does not purport to have any affiliation with the CDC.","\n","\n","The information provided by this App, including the text, images, and graphics (collectively, \u201cInformation\u201d) is intended to serve as a reference for physicians and healthcare professionals. The Information provided in this App is not meant to serve as a substitute for your own clinical judgment as a physician or healthcare professional. You should continue to evaluate and independently verify the Information provided herein. Nothing contained in this App is intended to be used as a substitute for your ultimate medical diagnosis or treatment. The Information is designed to support, and not replace, the relationship that exists between physicians or healthcare professionals and their patients and is not intended, nor recommended as a substitute for professional medical advice.","\n","\n","If you are a patient you should always consult your physician or healthcare professional if you have questions about your symptoms, diagnosis or treatment.","\n","\n","Use of Information and User Restrictions GBG grants you the non-exclusive, non-transferrable, limited right and permission to use this App solely for your personal, non-commercial use in the United States and to download and install this App on a single mobile device owned or otherwise controlled by you.","\n","\n","The Information is protected by copyright under both United States and foreign laws. Any use of the Information not expressly permitted by the Terms is a breach of the Terms and may violate copyright, trademark, and other laws. All rights not expressly granted herein are reserved to GBG. If you violate any of the Terms, your permission to use the App automatically terminates.","\n","\n","You acknowledge, consent and agree that we may investigate your use of the App in order to determine whether a violation of the Terms has occurred or to comply with any applicable laws, regulations, governmental requests or legal processes.","\n","\n","Changes to Terms GBG reserves the right to update or modify the Terms at any time without prior notice to you. Your use of the App after the Terms have been updated shall be deemed to constitute acceptance by you of any modifications, additions or deletions to the updated Terms.","\n","\n","Privacy GBG does not collect any information from you when downloading or using our App. You are responsible for assessing your privacy and security needs and determining whether your use of our App is appropriate to comply with your obligations.","\n","\n","Jurisdiction GBG controls the components of the App made available to you from within the State of New Jersey. By downloading the App, you agree that the statutes and laws of the State of New Jersey, without regard to choice of laws principles, will apply to all matters relating to your use of the App. No waiver of any of the Terms shall be deemed a further or continuing waiver of the Terms. We make no representation that materials made available through the App are appropriate or available for use in other locations, and accessing them from territories where their contents are illegal is prohibited. If you access the App from outside the United States, you are responsible for compliance with the laws of that foreign jurisdiction.","\n","\n","Termination and Modification You agree that, under certain circumstances and without prior notice to you, GBG may either temporarily or permanently discontinue the App. Cause for termination shall include, but is not limited to: (a) breaches or violations of the Terms; (b) requests by law enforcement or other government agencies; (c) discontinuance or material modification to the mobile application; or (d) unexpected technical or security issues or problems. You agree that all terminations for cause shall be made at our sole discretion, and we shall not be liable to you for termination of access to the App.","\n","\n","The provisions of Disclaimer, Use of Information and User Restrictions, Jurisdiction, Disclaimer of Liability and Indemnity shall survive the expiration or termination of the Terms.","\n","\n",'Disclaimer of Liability The App and Information included therein are provided on an "as is" basis. WE DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, ACCURACY, NON-INFRINGEMENT OF THIRD PARTIES\' RIGHTS, FITNESS FOR PARTICULAR PURPOSE AND THAT THE SERVICES WILL MEET YOUR REQUIREMENTS AS AN END USER OF THE SERVICES.',"\n","\n","When using the App, information will be transmitted over a medium that may be beyond GBG\u2019s control. Accordingly, GBG does not assume liability for or relating to the delay, failure, interruption or corruption of Information transmitted in connection with your use of the App. You are responsible for obtaining and maintaining all connectivity, software, hardware and other equipment needed to access the App and all charges related to the same.","\n","\n","You agree that you must evaluate, and bear all risks associated with, the use of the Information contained in the App, including any reliance on the accuracy, completeness, or usefulness of such Information.","\n","\n","Without limiting the foregoing, GBG makes no representations or warranties to: (1) the accuracy, reliability, completeness, currentness, or timeliness of the Information, software, text, graphics, links, or communications provided on or through the use of the App; and (2) the satisfaction of any government regulations requiring disclosure of information on prescription drug products.","\n","\n","In no event will we be liable for any damages (including, without limitation, incidental, consequential and special damages, personal injury/wrongful death, lost profits for sequence, accuracy or completeness of Information included in the App, or damages resulting from lost data or business interruption) arising out of or in connection with the use of, misuse of, inability to use or interpretation of the Information contained in the App, whether based on warranty, contract, tort, or any other legal theory, and whether or not we are advised of the possibility of such damages.","\n","\n","Indemnity You agree to defend, indemnify, and hold GBG and our officers, directors, employees, agents, licensors, and suppliers, harmless from and against any claims, actions or demands, liabilities and settlements including without limitation, reasonable legal and accounting fees, resulting from your use of or access to the App, or alleged to result from your violation of the Terms.","\n","\n",'Take Down Notice and Procedures Pursuant to the Digital Millennium Copyright Act of 1998 ("DMCA") 17 U.S.C. \xa7 512(c)(1)(A), if you believe any materials accessible on or from the App infringe your copyright, you may request removal of those materials (or access thereto) from the App by providing the following information:',"\n","\n","1. Identification of the copyrighted work that you believe to be infringed. Please describe the work, and where possible include a copy or the location of an authorized version of the work.","\n","\n","2. Identification of the material that you believe to be infringing and its location. Please describe the material and any other pertinent information that will allow us to locate the material.","\n","\n","3. Your name, address, telephone number and e-mail address.","\n","\n","4. A statement that you have a good faith belief that the complained of use of the material is not authorized by the copyright owner, its agent, or the law.","\n","\n",'5. A statement that the information that you have supplied is accurate, and indicating that "under penalty of perjury," you are the copyright owner or are authorized to act on the copyright owner\'s behalf.',"\n","\n","6. A signature or the electronic equivalent from the copyright holder or authorized representative.","\n","\n","Significant failure to follow these guidelines may result in inadequate notice of the copyright infringement alleged under 17 U.S.C. \xa7 512(c)(3)(B).","\n","\n","Deliver this Notice, with all items completed to GBG\u2019s Designated Copyright Agent:","\n","\n","Genesis Biotechnology Group, LLC Legal Department 2439 Kuser Road Hamilton, NJ 08690 Email: agent@genesisbiotechgroup.com","\n","\n","Complete Agreement The Terms constitute the entire agreement between you and GBG with respect to your use of the App."]})})})};var Ye=(0,Le.default)();var qe=i.default.create({tabBarLabel:{color:"#d2e1f0",fontSize:10},tabContainer:{height:60,backgroundColor:"#d2e1f0"}});const Je=function(){return(0,R.jsxs)(Ye.Navigator,{screenOptions:function(e){var t=e.route;return{tabBarIcon:function(e){e.focused;var n,r=e.color,o=e.size;return"HomeTab"===t.name?n="home":"TestScreen"===t.name?n="disease":"TableOfContents"===t.name?n="notes-medical":"TermsOfUse"===t.name&&(n="file"),(0,R.jsx)(Se.default,{name:n,size:o,color:r})},tabBarStyle:{backgroundColor:"skyblue"},tabBarActiveTintColor:"#0000b3",tabBarInactiveTintColor:"gray"}},children:[(0,R.jsx)(Ye.Screen,{style:qe.tabBarLabel,name:"HomeTab",component:Ce,options:{headerShown:!1,tabBarLabel:"Home"}}),(0,R.jsx)(Ye.Screen,{style:qe.tabBarLabel,name:"TestScreen",component:_e,options:{headerTitle:"Tests",headerStyle:{backgroundColor:"#0080ff",height:50},tabBarLabel:"Tests"}}),(0,R.jsx)(Ye.Screen,{style:qe.tabBarLabel,name:"TableOfContents",component:De,options:{headerTitle:"Notes",headerStyle:{backgroundColor:"#0080ff",height:50},tabBarLabel:"Notes"}}),(0,R.jsx)(Ye.Screen,{style:qe.tabBarLabel,tabBarLabel:!0,name:"TermsOfUse",titleNumberOfLines:4,component:Fe,options:{headerTitle:"Terms Of Use",headerStyle:{backgroundColor:"#0080ff",height:50},tabBarLabel:"Terms Of Use"}})]})};var Ze=(0,j.default)();const Ke=function(){return(0,R.jsxs)(Ze.Navigator,{children:[(0,R.jsx)(Ze.Screen,{name:"HomeTab1",component:Je,options:{headerShown:!1,headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"MDL",component:re,options:{title:"MDL",headerStyle:{backgroundColor:"#0080ff"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"IDC10",component:X,options:{title:"Commonly Used IDC10 Codes",headerStyle:{backgroundColor:"#0080ff"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"Cervicitis",component:z,options:{title:"Cervicitis",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"Bacterial_Vaginosis",component:I,options:{title:"Bacterial Vaginosis",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"Chlamydial_Infections",component:V,options:{title:"Chlamydia trachomatis",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"Epididymitis",component:B,options:{title:"Epididymitis",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"HSV",component:K,options:{title:"Genital Herpes Simplex",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"HPV",component:q,options:{title:"Human Papillomavirus (Genital Warts)",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"Gonococcal_Infections",component:_,options:{title:"Neisseria gonorhoeae",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"Lymphogranuloma_Venereum",component:te,options:{title:"Lymphogranuloma Venereum",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"Nongonococcal_Urethritis",component:le,options:{title:"Nongonococcal Urethritis (NGU)",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"Mgent",component:de,options:{title:"Mycoplasma genitalium",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"Avag",component:fe,options:{title:"Aerobic vaginitis",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"Pelvic_Inflammatory_Disease",component:ye,options:{title:"Pelvic Inflammatory Disease",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"VVC",component:be,options:{title:"Vulvovaginal candidiasis",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"Syphilis",component:Oe,options:{title:"Treponema pallidum",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}}),(0,R.jsx)(Ze.Screen,{name:"Trichomoniasis",component:Te,options:{title:"Trichomonas vaginalis",headerStyle:{backgroundColor:"#ADD8E6"},headerTintColor:"#ffffff",headerTitleStyle:{fontWeight:"bold"}}})]})};var Qe={TestScreen:"TestScreen",TableOfContents:"TableOfContents",TermsOfUse:"TermsOfUse",MDL:"MDL",IDC10:"IDC10",StackNavigator:"StackNavigator",HomeScreen:"HomeTab"},Xe=[{name:Qe.StackNavigator,focusedRoute:Qe.StackNavigator,title:"",showInTab:!1,showInDrawer:!1,icon:function(e){return(0,R.jsx)(Se.default,{iconName:"home",size:20,color:e?"#ffffff18":"#333"})}},{name:Qe.HomeScreen,focusedRoute:Qe.HomeTab,title:"Home",showInTab:!0,showInDrawer:!0,icon:function(e){return(0,R.jsx)(Se.default,{iconname:"home",size:20,color:"#333"})}},{name:Qe.TestScreen,focusedRoute:Qe.TestScreen,title:"Tests",showInTab:!0,showInDrawer:!0,icon:function(e){return(0,R.jsx)(Se.default,{iconName:"disease",size:20,color:"#333"})}},{name:Qe.TableOfContents,focusedRoute:Qe.TableOfContents,title:"Notes",showInTab:!0,showInDrawer:!0,icon:function(e){return(0,R.jsx)(Se.default,{name:"info-circle",size:20,color:"#fff"})}},{name:Qe.TermsOfUse,focusedRoute:Qe.TermsOfUse,title:"TermsOfUse",showInTab:!0,showInDrawer:!0,icon:function(e){return(0,R.jsx)(Icon,{name:"yes",size:30,color:e?"#ffffff":"#000"})}},{name:Qe.MDL,focusedRoute:Qe.MDL,title:"About MDL",showInTab:!1,showInDrawer:!0,icon:function(e){return(0,R.jsx)(Icon,{name:"home",size:30,color:e?"#551E18":"#000"})}},{name:Qe.IDC10,focusedRoute:Qe.IDC10,title:"IDC10 Codes",showInTab:!1,showInDrawer:!0,icon:function(e){return(0,R.jsx)(Icon,{name:"home",size:30,color:e?"#551E18":"#000"})}}];function $e(e,t){var n=Object.keys(e);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);t&&(r=r.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),n.push.apply(n,r)}return n}function et(e){for(var t=1;t<arguments.length;t++){var n=null!=arguments[t]?arguments[t]:{};t%2?$e(Object(n),!0).forEach((function(t){(0,u.default)(e,t,n[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(n)):$e(Object(n)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(n,t))}))}return e}var tt=m.default.get("window").width,nt=(m.default.get("window").height,(0,x.default)()),rt=function(e){var t,r=null==(t=e.nav())?void 0:t.getCurrentRoute().name;return(0,R.jsxs)(p.default,et(et({},e),{},{children:[(0,R.jsx)((function(e){return(0,R.jsx)(y.default,{style:{flexDirection:"row",justifyContent:"space-between",alignItems:"center",padding:20,backgroundColor:"#f6f6f6",marginBottom:20},children:(0,R.jsx)(y.default,{children:(0,R.jsx)("img",{style:{flex:1},src:n(3648)})})})}),{}),Xe.filter((function(e){return e.showInDrawer})).map((function(t){var n=Xe.find((function(e){return e.name===r})),o=n?t.name===(null==n?void 0:n.focusedRoute):t.name===Qe.HomeScreen;return(0,R.jsx)(b.default,{label:function(){return(0,R.jsx)(f.default,{style:o?ot.drawerLabelFocused:ot.drawerLabel,children:t.title})},onPress:function(){return e.navigation.navigate(t.name)},style:[ot.drawerItem,o?ot.drawerItemFocused:null]},t.name)}))]}))},ot=i.default.create({headerLeft:{marginLeft:20},headerTitle:{color:"white",fontSize:20,fontWeight:"500",justifyContent:"center",alignItems:"center",flex:1},headerRight:{marginRight:20},drawerLabel:{fontSize:14},drawerLabelFocused:{fontSize:16,color:"#551E18",fontWeight:"500"},drawerItem:{height:60,justifyContent:"center"},drawerItemFocused:{backgroundColor:"#0080ff"},Image:{margin:.55*tt}});const it=function(e){var t=e.nav;return(0,R.jsx)(nt.Navigator,{screenOptions:function(e){var t=e.navigation;return{headerShown:!0,headerStyle:{backgroundColor:"#0000b3",height:50},headerLeft:function(){return(0,R.jsx)(h.default,{onPress:function(){return t.toggleDrawer()},style:ot.headerLeft,children:(0,R.jsx)(g.default,{name:"bars",size:20,color:"#fff"})})}}},drawerContent:function(e){return(0,R.jsx)(rt,et(et({},e),{},{nav:t}))},children:(0,R.jsx)(nt.Screen,{name:Qe.StackNavigator,component:Ke,options:{title:"",headerRight:function(){return(0,R.jsx)(h.default,{onPress:function(){return alert("About this App \n This App was created by Jon Sniffen; Medical Diagnostic Laboratories, and reflects recommended regimens found in CDCs Sexually Transmitted Infections Treatment Guidelines, 2021. This summary is intended as a source of clinical guidance. When more than one therapeutic regimen is recommended, the sequence is in alphabetical order unless the choices for therapy are prioritized based on efficacy, cost, or convenience. The recommended regimens should be used primarily; alternative regimens can be considered in instances of substantial drug allergy or other contraindications. An important component of STI treatment is partner management. Providers can arrange for the evaluation and treatment of sex partners either directly or with assistance from state and local health departments. Complete guidelines can be found online at www.cdc.gov/std/treatment.")},style:ot.headerRight,children:(0,R.jsx)(g.default,{name:"info-circle",size:20,color:"#fff"})})}}})})};var lt=Boolean("localhost"===window.location.hostname||"[::1]"===window.location.hostname||window.location.hostname.match(/^127(?:\.(?:25[0-5]|2[0-4][0-9]|[01]?[0-9][0-9]?)){3}$/));function at(e,t){navigator.serviceWorker.register(e).then((function(e){e.onupdatefound=function(){var n=e.installing;null!=n&&(n.onstatechange=function(){"installed"===n.state&&(navigator.serviceWorker.controller?(console.log("New content is available and will be used when all tabs for this page are closed. See https://cra.link/PWA."),t&&t.onUpdate&&t.onUpdate(e)):(console.log("Content is cached for offline use."),t&&t.onSuccess&&t.onSuccess(e)))})}})).catch((function(e){console.error("Error during service worker registration:",e)}))}var st=a.createRef(),dt=function(){return st.current},ct=i.default.create({safeArea:{flex:"1",overflow:"hidden"}});!function(e){if("serviceWorker"in navigator){if(new URL("/tg/web-build",window.location.href).origin!==window.location.origin)return;window.addEventListener("load",(function(){var t="/tg/web-build/service-worker.js";lt?(!function(e,t){fetch(e,{headers:{"Service-Worker":"script"}}).then((function(n){var r=n.headers.get("content-type");404===n.status||null!=r&&-1===r.indexOf("javascript")?navigator.serviceWorker.ready.then((function(e){e.unregister().then((function(){window.location.reload()}))})):at(e,t)})).catch((function(){console.log("No internet connection found. App is running in offline mode.")}))}(t,e),navigator.serviceWorker.ready.then((function(){console.log("This web app is being served cache-first by a service worker. To learn more, visit https://cra.link/PWA")}))):at(t,e)}))}}();const ut=function(){var e=(0,a.useState)(1),t=(0,o.default)(e,2),n=(t[0],t[1]);(0,a.useEffect)((function(){i()}),[]);var i=function(){var e=(0,r.default)((function*(){yield s.lockAsync(d.OrientationLock.PORTRAIT_UP);var e=yield s.getOrientationAsync();n(e)}));return function(){return e.apply(this,arguments)}}();return(0,R.jsx)(l.default,{style:ct.safeArea,children:(0,R.jsx)(c.default,{ref:st,children:(0,R.jsx)(it,{nav:dt})})})}},3648:(e,t,n)=>{e.exports=n.p+"static/media/MDLLogo2022small.a8d755c3e47aee7e7220.png"},1429:(e,t,n)=>{e.exports=n.p+"static/media/STDGuideLines_Treatments_ICD10_2021_NewLogo_Page_1.a8cab2edf223ccf3cd0a.jpg"},9129:(e,t,n)=>{e.exports=n.p+"static/media/dnatrans3.fab46885fa347fe3a3dd.png"}},t={};function n(r){var o=t[r];if(void 0!==o)return o.exports;var i=t[r]={id:r,loaded:!1,exports:{}};return e[r].call(i.exports,i,i.exports,n),i.loaded=!0,i.exports}n.m=e,(()=>{var e=[];n.O=(t,r,o,i)=>{if(!r){var l=1/0;for(c=0;c<e.length;c++){for(var[r,o,i]=e[c],a=!0,s=0;s<r.length;s++)(!1&i||l>=i)&&Object.keys(n.O).every((e=>n.O[e](r[s])))?r.splice(s--,1):(a=!1,i<l&&(l=i));if(a){e.splice(c--,1);var d=o();void 0!==d&&(t=d)}}return t}i=i||0;for(var c=e.length;c>0&&e[c-1][2]>i;c--)e[c]=e[c-1];e[c]=[r,o,i]}})(),n.n=e=>{var t=e&&e.__esModule?()=>e.default:()=>e;return n.d(t,{a:t}),t},(()=>{var e,t=Object.getPrototypeOf?e=>Object.getPrototypeOf(e):e=>e.__proto__;n.t=function(r,o){if(1&o&&(r=this(r)),8&o)return r;if("object"===typeof r&&r){if(4&o&&r.__esModule)return r;if(16&o&&"function"===typeof r.then)return r}var i=Object.create(null);n.r(i);var l={};e=e||[null,t({}),t([]),t(t)];for(var a=2&o&&r;"object"==typeof a&&!~e.indexOf(a);a=t(a))Object.getOwnPropertyNames(a).forEach((e=>l[e]=()=>r[e]));return l.default=()=>r,n.d(i,l),i}})(),n.d=(e,t)=>{for(var r in t)n.o(t,r)&&!n.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},n.g=function(){if("object"===typeof globalThis)return globalThis;try{return this||new Function("return this")()}catch(e){if("object"===typeof window)return window}}(),n.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),n.r=e=>{"undefined"!==typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},n.nmd=e=>(e.paths=[],e.children||(e.children=[]),e),n.p="/tg/web-build/",(()=>{var e={179:0};n.O.j=t=>0===e[t];var t=(t,r)=>{var o,i,[l,a,s]=r,d=0;if(l.some((t=>0!==e[t]))){for(o in a)n.o(a,o)&&(n.m[o]=a[o]);if(s)var c=s(n)}for(t&&t(r);d<l.length;d++)i=l[d],n.o(e,i)&&e[i]&&e[i][0](),e[i]=0;return n.O(c)},r=self.webpackChunkweb=self.webpackChunkweb||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})();var r=n.O(void 0,[197],(()=>n(5530)));r=n.O(r)})();
//# sourceMappingURL=main.01823159.js.map
